RE:RE:RE:RE:RE:CYDY To be fair it should go.
Chat > fda accept > start dosing patients
In THTX's case it's gone.
Chat > harmonize > chat > change to general NASH > chat > may proceed letter > chat > final protocol > chat with some new guys > .... and still no needles in patients
Every time they've appeared to take a step forward they've caveated it with a "we can't actually get this going yet".
I was thinking what's the best analogy. I've got a drunk man trying to move up a down escalator. Or Frankstein's monster lying on the slab, everything looks right but the storm keeps missing the house or the fuses blow. Not getting that final jolt of electricity and the poor things turning green and a bit smelly.
You'd expect fda approval to signal a living clinical program, there's still no life. No patients getting dosed, that is dominating over the fda nod.
Bucknelly21 wrote:
weren't you the one who said Nash would have value after the protocols and fda accepted the phase 3?
jfm1330 wrote: The oddity is Cytodyn, not Thera. If Thera get excellent results in oncology and the SP barely moves, than I will blame the management for not being able to sell a real good story. At this point, oncology is hope of a good story based on educated guesses by us, but this is not a confirmed fact. Possibility of failure or mild results is there. And again, I looked at Sutro, and even with good efficacy data on humans, their valuation is not very high. So even with some proof of efficacy, the SP will not go crazy. It should rise, maybe double, but not more than that unless results would be really spectacular.
SPCEO1 wrote: Even with the inevitable happening to CYDY (and still in the process of happening - how much longer before their CEO flees the country I wonder), it still has a market cap of $463 million versus TH's $274 million. So, despite the insanity at CYDY, investors somehow value it more highly than TH. Life is weird - very, very weird!
jfm1330 wrote: 0.70$ today, less than a year ago it was at 7.15$. So much for "promotion" I guess...